专利详细信息
专利号 | WO2014005606A1 |
专利标题 | STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF |
专利权人 | PHARMATHEN SA [GR];KARAVAS EVANGELOS [GR];KOUTRIS EFTHIMOS [GR];BIKIARIS DIMITRIOS [GR];CHATIDOU SOTIRIA [GR];DIAKIDOU AMALIA [GR];BARMPALEXIS PANAGIOTIS [GR];KONSTANTI LOUIZA [GR];MINIOTI KATERINA [GR]; |
发明人 | KARAVAS EVANGELOS [GR];KOUTRIS EFTHIMOS [GR];BIKIARIS DIMITRIOS [GR];CHATIDOU SOTIRIA [GR];DIAKIDOU AMALIA [GR];BARMPALEXIS PANAGIOTIS [GR];KONSTANTI LOUIZA [GR];MINIOTI KATERINA [GR]; |
申请号 | WO2012EP02854 |
申请日 | 2012/7/6 |
公开日 | 2014/1/9 |
优先权号 | |
IPC | A61K31/165; A61K9/00; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The present invention relates to a controlled release sterile injectable formulation in the form of solution, suspension or sol-gel formulation for intramuscular or subcutaneous administration comprising a therapeutically effective amount of a neurokinin 1 receptor antagonist, in particular Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof. It also relates to a process for developing such formulations.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。